• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌胃肠道转移:PD-L1 表达与相关临床病理变量。

Gastrointestinal tract metastasis of lung cancer: The PD-L1 expression and correlated clinicopathological variables.

机构信息

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

出版信息

Pathol Int. 2021 Jan;71(1):33-41. doi: 10.1111/pin.13048. Epub 2020 Dec 1.

DOI:10.1111/pin.13048
PMID:33259707
Abstract

The gastrointestinal tract is a rare site for metastatic lung cancer. Programmed cell death-ligand 1 (PD-L1) expression in lung cancer is a biomarker for the response to anti-PD-1/PD-L1 therapy. We investigated clinicopathological features and PD-L1 expression in 25 gastrointestinal metastatic tumors from the lung and primary adenocarcinoma of the small bowel. The small bowel was the most common site (16/25; 64%) of gastrointestinal tract lung cancer metastasis. A total of 19 (76%) of the gastrointestinal metastasis showed PD-L1 expression in ≥5% of tumor cells, with 14 (56%) showing high expression levels (≥50%). In contrast, 21 (84%) expressed PD-L1 in ≥5% immune cells, including 4 (16%) showing a high expression levels (≥50%). The PD-L1 expression on tumor cells and immune cells in primary lung cancer and corresponding gastrointestinal metastasis was concordant in 13 (68%) and 11 (58%) of the 19 paired cases, respectively. Small-bowel metastasis of lung cancer was characterized by a higher incidence of perforation (31% vs. 0%), ulcerated mass (83% vs. 60%), and neoplastic PD-L1 expression (75% vs. 0%) compared to primary small-bowel adenocarcinoma. Gastrointestinal metastasis from lung cancer might be a potential target for immune checkpoint inhibitor therapy, given its high expression of PD-L1.

摘要

胃肠道是肺癌转移的罕见部位。肺癌中程序性死亡配体 1(PD-L1)的表达是对抗 PD-1/PD-L1 治疗反应的生物标志物。我们研究了 25 例来自肺部的胃肠道转移性肿瘤和原发性小肠腺癌的临床病理特征和 PD-L1 表达。小肠是胃肠道肺癌转移的最常见部位(16/25;64%)。总共 19 例(76%)胃肠道转移显示肿瘤细胞中 PD-L1 表达≥5%,其中 14 例(56%)显示高表达水平(≥50%)。相比之下,21 例(84%)在≥5%的免疫细胞中表达 PD-L1,包括 4 例(16%)显示高表达水平(≥50%)。在 19 对配对病例中,肿瘤细胞和免疫细胞上的 PD-L1 表达在原发性肺癌和相应的胃肠道转移中分别有 13 例(68%)和 11 例(58%)是一致的。与原发性小肠腺癌相比,肺癌的小肠转移穿孔(31%对 0%)、溃疡性肿块(83%对 60%)和肿瘤 PD-L1 表达(75%对 0%)的发生率更高。鉴于其 PD-L1 的高表达,来自肺癌的胃肠道转移可能是免疫检查点抑制剂治疗的潜在靶点。

相似文献

1
Gastrointestinal tract metastasis of lung cancer: The PD-L1 expression and correlated clinicopathological variables.肺癌胃肠道转移:PD-L1 表达与相关临床病理变量。
Pathol Int. 2021 Jan;71(1):33-41. doi: 10.1111/pin.13048. Epub 2020 Dec 1.
2
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.不同于浸润免疫细胞,肺癌细胞的 PD-L1 表达在脑转移期间稳定且不受治疗影响。
Clin Lung Cancer. 2019 Sep;20(5):363-369.e2. doi: 10.1016/j.cllc.2019.05.008. Epub 2019 May 15.
3
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.程序性细胞死亡配体1(PD-L1)、CD8 +肿瘤浸润淋巴细胞和p53在非小细胞肺癌中的预后意义:一项免疫组织化学研究
Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398.
4
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.程序性死亡细胞配体1(PD-L1)与I期非小细胞肺癌的生存率相关。
Semin Thorac Cardiovasc Surg. 2017;29(3):408-415. doi: 10.1053/j.semtcvs.2017.05.008. Epub 2017 May 26.
5
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.程序性细胞死亡配体-1在肺腺癌中的表达的临床病理及预后意义及其与p53状态的关系
Lung Cancer. 2016 Jul;97:73-80. doi: 10.1016/j.lungcan.2016.05.001. Epub 2016 May 3.
6
Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.免疫治疗与非小细胞肺癌患者生存及免疫相关生物标志物的相关性:一项荟萃分析和个体患者水平分析。
JAMA Netw Open. 2019 Jul 3;2(7):e196879. doi: 10.1001/jamanetworkopen.2019.6879.
7
Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry.准确表达 PD-L1/L2 在肺腺癌细胞中的作用:一项采用双重免疫组化的回顾性研究。
Cancer Sci. 2019 Sep;110(9):2711-2721. doi: 10.1111/cas.14128. Epub 2019 Jul 31.
8
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.PD-L1表达及PD-L1基因多态性与肺腺癌和肺鳞癌预后不良的相关性
Hum Pathol. 2017 Oct;68:103-111. doi: 10.1016/j.humpath.2017.08.016. Epub 2017 Aug 26.
9
Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).表达程序性细胞死亡配体1(PD-L1)的肺癌的临床和病理特征
Lung Cancer. 2016 Aug;98:69-75. doi: 10.1016/j.lungcan.2016.04.021. Epub 2016 May 25.
10
Programmed death-ligand 1 expression on direct Pap-stained cytology smears from non-small cell lung cancer: Comparison with cell blocks and surgical resection specimens.程序性死亡配体 1 在非小细胞肺癌直接巴氏染色细胞学涂片上的表达:与细胞块和手术切除标本的比较。
Cancer Cytopathol. 2019 Jul;127(7):470-480. doi: 10.1002/cncy.22155. Epub 2019 Jun 27.

引用本文的文献

1
The analysis about the metastases to Gastrointestinal tract: a literature review, 2000-2023.关于胃肠道转移的分析:一项2000年至2023年的文献综述
Front Oncol. 2025 Apr 17;15:1552932. doi: 10.3389/fonc.2025.1552932. eCollection 2025.
2
The current status and future of PD-L1 in liver cancer.肝癌中 PD-L1 的现状和未来。
Front Immunol. 2023 Dec 12;14:1323581. doi: 10.3389/fimmu.2023.1323581. eCollection 2023.
3
Gastrointestinal bleeding due to jejunal metastasis of pleomorphic lung carcinoma: a case report.多形性肺癌空肠转移导致的消化道出血:一例报告
Ann Med Surg (Lond). 2023 Mar 27;85(4):1119-1122. doi: 10.1097/MS9.0000000000000364. eCollection 2023 Apr.
4
Gene profiling of metastatic small intestinal squamous cell carcinoma after lung squamous cell carcinoma surgery: a case report.肺鳞状细胞癌手术后转移性小肠鳞状细胞癌的基因谱分析:一例报告
Transl Cancer Res. 2022 Apr;11(4):967-972. doi: 10.21037/tcr-22-481.
5
Persistent fecal occult blood due to the small intestinal metastasis of pleomorphic lung carcinoma.多形性肺癌小肠转移导致持续性粪便潜血。
J Surg Case Rep. 2022 Feb 19;2022(2):rjac043. doi: 10.1093/jscr/rjac043. eCollection 2022 Feb.